Status:
TERMINATED
Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Post-Dural Puncture Headache
Sphenopalatine Ganglion Block
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).
Detailed Description
The primary objectives of the study are to study the effectiveness of SP ganglion block in relieving post-dural puncture headache in terms of : 1. Number of subjects who get relief of pain 2. The ons...
Eligibility Criteria
Inclusion
- Complains of symptoms suggestive of post-dural puncture headache
- Has a history of dural puncture (lumbar puncture or accidental dural puncture during epidural placement) within the previous 7 days
- Fluent in written and spoken English
Exclusion
- Those with a known history of hypersensitivity to local anesthetics of the amide type or to other components of GLYDO
- Those with any congenital or acquired, anatomical deformity of the nostril, which preclude performing the block
- Those who refuse to consent to participate in the study
- Patients who have had a failed epidural blood patch
- Cognitive Impairment
- Prisoner
Key Trial Info
Start Date :
May 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2022
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03430531
Start Date
May 31 2019
End Date
March 11 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States, 17033